Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals has informed the exchanges that its trading window will be closed starting October 1, 2025, in line with SEBI's Insider Trading Regulations. The window will reopen 48 hours after the company declares its unaudited financial results for the second quarter ending September 30, 2025. During this period, designated persons (such as directors, key managerial personnel) and their immediate relatives are prohibited from trading in the company's shares. The letter was signed by Company Secretary Mohanachandran A on September 26, 2025.
This is a routine compliance announcement and does not affect shareholders directly. It signals that the company's Q2 FY26 results will be announced in the coming weeks, which could be a near-term catalyst for the stock.